LJUBLJANA (Slovenia), December 23 (SeeNews) – Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] said on Wednesday it targets a consolidated net profit of 8.8 million euro ($10.7 million) in 2021.
Salus plans consolidated net sales revenue of 415 million euro next year, backed by increased business volume and the introduction of new services, the company said in a statement.
The group's 2021 operating profit is projected at 10.8 million euro. EBITDA (earnings before interest, taxes, depreciation, and amortisation) is planned at 15.2 million euro.
The company intends to invest in information technology, as well as in facilities and equipment in order to improve the efficiency and profitability of its operations in the coming years.
The Salus group comprises nine companies based in Slovenia, Croatia, Serbia and North Macedonia.
Salus said earlier it expects to report a 5.7 million euro consolidated net profit in full year 2020 on the back of net sales revenue of 350 million euro. The group beat its own profit forecast already in the first nine months, reporting a consolidated net profit of 6.76 million euro, up 56% year-on-year, with consolidated net sales up 15% to over 292 million euro but noted that due to the uncertainty caused by the Covid-19 pandemic it was impossible to estimate at that point in time to what extent the plan will be outperformed.
The company's shares last traded on the Ljubljana Stock Exchange on December 22, closing 1.15% higher at 880 euro.
($=0.821413 euro)